Human IgG antibody Laboratories manufactures the vegf-165 vegf-a isoform reagents distributed by Genprice. The Vegf-165 Vegf-A Isoform reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact vegf assay. Other Vegf-165 products are available in stock. Specificity: Vegf-165 Category: Vegf-A Group: Isoform
Human VEGF 165 Antibody (Biotin Conjugate) |
AssayPro |
150 ug |
EUR 442.8 |
Recombinant human VEGF 165 Protein |
Abclonal |
5 μg |
EUR 181.2 |
VEGF 165 Recombinant Protein |
ProSci |
0.05 mg |
EUR 714.3 |
Description: VEGF165 is the most abundant splice variant of VEGF-A. VEGF165 is produced by a number of cells including endothelial cells, macrophages and T cells. VEGF165 is involved in angiogenesis, vascular endothelial cell survival, growth, migration and vascular permeability. VEGF gene expression is induced by hypoxia, inflammatory cytokines and oncogenes. VEGF165 binds to heparan sulfate and is retained on the cell surface and in the extracellular matrix. VEGF165 binds to the receptor tyrosine kinases, VEGFR1 and VEGFR2. VEGF165 is the only splice variant that binds to co-receptors NRP-1 and NRP-2 that function to enhance VEGFR2 signaling. Binding of VEGF165 to VEGFR1 and VEGFR2 leads to activation of the PI3K/AKT, p38 MAPK, FAK and paxillin. VEGF plays a key role in tumor angiogenesis in many cancers. |
Isoform information
VEGF-165-Fc |
E13-m006-2 |
EnoGene |
50μg |
EUR 1386 |
VEGF-165 (His tag) |
EGPS004 |
EnoGene |
10ug |
EUR 175 |
Human VEGF 165 Antibody |
32563-05111 |
AssayPro |
150 ug |
EUR 313.2 |
VEGF 165 Recombinant Protein |
96-772 |
ProSci |
0.05 mg |
EUR 714.3 |
Description: VEGF165 is the most abundant splice variant of VEGF-A. VEGF165 is produced by a number of cells including endothelial cells, macrophages and T cells. VEGF165 is involved in angiogenesis, vascular endothelial cell survival, growth, migration and vascular permeability. VEGF gene expression is induced by hypoxia, inflammatory cytokines and oncogenes. VEGF165 binds to heparan sulfate and is retained on the cell surface and in the extracellular matrix. VEGF165 binds to the receptor tyrosine kinases, VEGFR1 and VEGFR2. VEGF165 is the only splice variant that binds to co-receptors NRP-1 and NRP-2 that function to enhance VEGFR2 signaling. Binding of VEGF165 to VEGFR1 and VEGFR2 leads to activation of the PI3K/AKT, p38 MAPK, FAK and paxillin. VEGF plays a key role in tumor angiogenesis in many cancers. |
VEGF 165 Recombinant Protein |
96-773 |
ProSci |
0.05 mg |
EUR 752.1 |
Description: VEGF165 is the most abundant splice variant of VEGF-A. VEGF165 is produced by a number of cells including endothelial cells, macrophages and T cells. VEGF165 is involved in angiogenesis, vascular endothelial cell survival, growth, migration and vascular permeability. VEGF gene expression is induced by hypoxia, inflammatory cytokines and oncogenes. VEGF165 binds to heparan sulfate and is retained on the cell surface and in the extracellular matrix. VEGF165 binds to the receptor tyrosine kinases, VEGFR1 and VEGFR2. VEGF165 is the only splice variant that binds to co-receptors NRP-1 and NRP-2 that function to enhance VEGFR2 signaling. Binding of VEGF165 to VEGFR1 and VEGFR2 leads to activation of the PI3K/AKT, p38 MAPK, FAK and paxillin. VEGF plays a key role in tumor angiogenesis in many cancers. |
VEGF-A(VEGF/1063) Antibody |
BNC941063-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF594 conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
BNC941063-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF594 conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
BNC801063-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF680 conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
BNC801063-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF680 conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
BNC811063-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF680R conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
BNC811063-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF680R conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
BNC701063-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF770 conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
BNC701063-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF770 conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
BNC881063-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF488A conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
BNC881063-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF488A conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
BNC051063-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF405M conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
BNC051063-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF405M conjugate, Concentration: 0.1mg/mL |